Filing
2nd Quarter - Termination
Lobbying activity
1
Issues surrounding Food and Drug Administration (FDA) oversight of dietary supplements; Federal Kratom Consumer Protection Act (H.R. 5905 & S. 3039; FDA Agriculture Appropriations FY25.